Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD.
Oluwafemi BalogunJeffrey Y WangEmad S ShaikhKarine LiuStefania StoyanovaZoe N MemelHayley SchultzLisa MunJack BertmanCheryl A RogenMaryam K IbrahimMadeline BerschbackEugenia Uche-AnyaRobert WilechanskyTracey G SimonKathleen E CoreyPublished in: Hepatology communications (2023)
Although diabetes is independently associated with hepatic fibrosis in patients with MASLD, the combination of tobacco consumption and diabetes is associated with a higher prevalence of fibrosis. Therefore, lifestyle change through tobacco use cessation in patients with diabetes could be beneficial in reducing the incidence of liver fibrosis among individuals with MASLD.